Document is current
Any future updates will be listed below
-
Authors
Howes, Oliver D. http://orcid.org/0000-0002-2928-1972
Onwordi, Ellis Chika
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MC_A656_5QD30_2135)
Maudsley Charity (666)
Wellcome Trust (094849/Z/10/Z)
National Institute for Health Research Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London
National Institute for Health and Care Research
- License Information
-
More Information
Article History
Received: 30 June 2022
Revised: 16 March 2023
Accepted: 20 March 2023
First Online: 11 April 2023
Competing interests
: ODH has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organised by Angelini, Autifony, Biogen, Boehringer Ingelheim, Eli Lilly, Heptares, Global Medical Education, Invicro, Janssen, Lundbeck, Neurocrine, Otsuka, Sunovion, Recordati, Roche and Viatris/Mylan and was a part time employee of H Lundbeck A/s. ODH has a patent for the use of dopaminergic imaging. No other conflicts of interest were declared.
